Description

5α,6β-Dibromostigmastan-3β-Yl 3-Acetate CAS NO 32212-73-0 is a brominated sterol derivative, a key synthetic intermediate in the production of specialized pharmaceutical compounds and advanced organic materials. Its precise molecular structure makes it a critical building block for researchers and manufacturers requiring high-purity, functionalized steroidal frameworks. This compound is primarily utilized by the pharmaceutical, biotechnology, and fine chemical synthesis industries for the development of novel therapeutic agents and high-value chemical entities.

Application

• Pharmaceutical Intermediate: Serves as a crucial precursor in the synthesis of novel steroidal drugs and active pharmaceutical ingredients (APIs).
• Biochemical Research: Used as a reference standard or a starting material in metabolic pathway studies and steroid hormone research.
• Fine Chemical Synthesis: Acts as a specialized building block for constructing complex organic molecules with specific stereochemistry.
• Material Science: Potential use in the development of advanced liquid crystals or specialty polymers derived from steroidal backbones.
• Academic & R&D Laboratories: Employed in method development and exploratory chemistry for new compound libraries.

Basic Information

Product Name	5α,6β-Dibromostigmastan-3β-Yl 3-Acetate
CAS No.	32212-73-0
Molecular Formula	C31H52Br2O2
Molecular Weight	616.56 g/mol
Synonyms	5α,6β-Dibromostigmastan-3β-yl acetate; 3β-Acetoxy-5α,6β-dibromostigmastane; Stigmastane-3β-ol, 5α,6β-dibromo-, acetate; 5α,6β-Dibromo-3β-acetoxystigmastane; (3β)-5α,6β-Dibromostigmastan-3-yl acetate; 5α,6β-Dibromostigmasteryl acetate derivative; Dibromostigmastanyl acetate
EINECS	Contact for details

Quality Control

Our 5α,6β-Dibromostigmastan-3β-Yl 3-Acetate is produced under strict quality management protocols to ensure batch-to-batch consistency and high purity suitable for research and synthesis. We provide comprehensive Certificates of Analysis (COA) with each batch, detailing key parameters such as purity, identity, and impurity profiles. Our quality commitment aligns with cGMP principles for pharmaceutical intermediates, ensuring reliability for critical applications.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (15-25°C). Keep the container tightly sealed to prevent contamination and moisture absorption.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 95.0%
Melting Point	Contact for details
Loss on Drying	≤ 1.0%
Residue on Ignition	≤ 0.5%
Single Unknown Impurity (HPLC)	≤ 1.0%
Total Impurities (HPLC)	≤ 5.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.